Analysts say early data showing Gilead Sciences Inc.’s remdesivir improved clinical outcomes for two-thirds of a small group of severely ill COVID-19 patients...
Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties






